Estrogen receptor quantitative measures and breast cancer survival.

Deirdre A HillMarc BarryCharles WigginsAndrea NibbeMelanie RoyceEric ProssnitzLesley Lomo

Published in: Breast cancer research and treatment (2017)

Estrogen receptor percent positive staining is not independently related to breast cancer survival after adjustment for other survival-related factors. ER intensity, in contrast, demonstrates promise for prognostic utility.

Keyphrases

estrogen receptor
free survival
magnetic resonance
magnetic resonance imaging
big data
computed tomography
young adults
contrast enhanced
deep learning